Analysis of Cardiovascular Disease Risk Factors in Women

  • Maria Stanislavovna Tairova Cardiovascular Rehabilitation Institute of Sports Medicine of Caxias do Sul, Caxias do Sul
  • Lucas Odacir Graciolli Cardiovascular Rehabilitation Institute of Sports Medicine of Caxias do Sul, Caxias do Sul
  • Olga Sergueevna Tairova Cardiovascular Rehabilitation Institute of Sports Medicine of Caxias do Sul, Caxias do Sul
  • Thiago De Marchi Faculdade Cenecista of Bento Gonçalves, Rio Grande do Sul
Keywords: Cardiovascular risk, Women, Coronary heart disease

Abstract

AIM: Study the cardiovascular risk factors in a feminine population vulnerable to cardiovascular events particularly to evaluate the principal factors or possible confounding variables.

METHODS: This is a cross-sectional descriptive study. Were analysed all the female patients from the Cardiovascular Rehabilitation Institute of Sports Medicine of Caxias do Sul who had the complete information on cardiovascular disease history, comorbidities and habits and who knew the complete gynaecological history by a phone interview.

RESULTS: Were analysed 91 patients. About the comorbidities and habits, 45.2% of these patients presented some tobacco load, 82.4% are hypertensive, 61.5% are dyslipidemic, 25.3% are diabetic and the BMI average was 29.27 (overweight). Between the patients who undergone a hysterectomy and had an episode of the acute coronary syndrome (10 patients), 70% had the event after the procedure. Between the post-menopause women with at least one episode of the acute coronary syndrome, 80.5% (33 patients) had the first event after the menopause.

CONCLUSION: We found multiple lifetime risk factors that predisposed the women of the sample to have cardiovascular disease. Between the women with specific to women risk factors and without, the prevalence of cardiovascular disease was very similar. This information supports the idea that these are just confounding factors of CVD and the principals involved are the genetic factors and habits. For this reason, the focus of CVD prevention and treatment should be directed towards these aspects.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986; 111(2):383–90. https://doi.org/10.1016/0002-8703(86)90155-9

Mondul AM, Rodriguez C, Jacobs EJ, Calle EE. Age at natural menopause and cause-specific mortality. Am J Epidemiol. 2005; 162(11):1089–97. https://doi.org/10.1093/aje/kwi324 PMid:16221806

Howard B V, Kuller L, Langer R, Manson JE, Allen C, Assaf A, et al. Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study. Circulation. 2005; 111(12):1462–70. https://doi.org/10.1161/01.CIR.0000159344.21672.FD PMid:15781742

Bertone-Johnson ER, Whitcomb BW, Rich-Edwards JW, Hankinson SE, Manson JE. Premenstrual Syndrome and Subsequent Risk of Hypertension in a Prospective Study. Am J Epidemiol. 2015; 182(12):1000–9. https://doi.org/10.1093/aje/kwv159

Cirillo PM, Cohn BA. Pregnancy complications and cardiovascular disease death: 50-year follow-up of the Child Health and Development Studies pregnancy cohort. Circulation. 2015; 132(13):1234–42. https://doi.org/10.1161/CIRCULATIONAHA.113.003901 PMid:26391409

Stadel B V. Oral contraceptives and cardiovascular disease (first of two parts). N Engl J Med. 1981; 305(11):612–8. https://doi.org/10.1056/NEJM198109103051104 PMid:7022208

WB K, DL M. Diabetes and cardiovascular disease: The framingham study. JAMA. 1979; 241(19):2035–8. https://doi.org/10.1001/jama.1979.03290450033020

Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE. The primary prevention of coronary heart disease in women. N Engl J Med. 1995; 332(26):1758–66. https://doi.org/10.1056/NEJM199506293322607 PMid:7760894

Orth-Gomer K, Mittleman MA, Schenck-Gustafsson K, Wamala SP, Eriksson M, Belkic K, et al. Lipoprotein(a) as a determinant of coronary heart disease in young women. Circulation. 1997; 95(2):329–34. https://doi.org/10.1161/01.CIR.95.2.329 PMid:9008445

Gus I, Ribeiro RA, Kato S, Bastos J, Medina C, Zazlavsky C, et al. Variations in the Prevalence of Risk Factors for Coronary Artery Disease in Rio Grande do Sul-Brazil: A Comparative Analysis between 2002 and 2014. Arquivos Brasileiros de Cardiologia. 2015; 105:573–9. https://doi.org/10.5935/abc.20150127

Lavie CJ, Bennett A, Arena R. Enhancing Cardiac Rehabilitation in Women. J Womens Health (Larchmt). 2017; 26(8):817–9. https://doi.org/10.1089/jwh.2017.6476 PMid:28613967

Gaudineau A, Ehlinger V, Vayssiere C, Jouret B, Arnaud C, Godeau E. Factors associated with early menarche: results from the French Health Behaviour in School-aged Children (HBSC) study. BMC Public Health. 2010; 10(1):175. https://doi.org/10.1186/1471-2458-10-175 PMid:20353570 PMCid:PMC2853511

Novak B. Tratado de Ginecologia, 2006.

Canonico M, Plu-Bureau G, O'Sullivan MJ, Stefanick ML, Cochrane B, Scarabin P-Y, et al. Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the Women's Health Initiative Hormone Therapy clinical trials. Menopause. 2014; 21(3):214–20. https://doi.org/10.1097/GME.0b013e31829752e0 PMid:23760439 PMCid:PMC3815514

Igho Pemu P, Ofili E. Hypertension in women: part I. J Clin Hypertens (Greenwich). 2008; 10(5):406–10. https://doi.org/10.1111/j.1751-7176.2008.06552.x

Franklin SS, Wong ND. Cardiovascular risk evaluation: an inexact science. Vol. 20, Journal of hypertension. England, 2002: 2127–30.

Garcez MR, Pereira JL, Fontanelli M de M, Marchioni DML, Fisberg RM. Prevalence of Dyslipidemia According to the Nutritional Status in a Representative Sample of São Paulo. Arquivos Brasileiros de Cardiologia. 2014; 103:476–84. https://doi.org/10.5935/abc.20140156

Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, Age, Cardiovascular Risk Factors, and Coronary Heart Disease. Circulation. 1999; 99(9):1165 -1172. https://doi.org/10.1161/01.CIR.99.9.1165 PMid:10069784

Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 63(25 Pt B):2889–934. https://doi.org/10.1016/j.jacc.2013.11.002

Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update: A Guideline From the American Heart Association. Circulation. 2011; 123: 1243–62. https://doi.org/10.1161/CIR.0b013e31820faaf8 PMid:21325087 PMCid:PMC3182143

Ceravolo GS, Tostes RC, Fortes ZB, de Carvalo MHC. Efeitos do estrógeno no sistema cardiovascular. Rev da Soc Bras Hipertens. 2007; 10:124–30.

Hu FB, Grodstein F, Hennekens CH, Colditz GA, Johnson M, Manson JE, et al. Age at natural menopause and risk of cardiovascular disease. Arch Intern Med. 1999; 159(10):1061–6. https://doi.org/10.1001/archinte.159.10.1061

Fuchs FD. Reposição hormonal e doença cardiovascular: uma diretriz contrária à evidência. Arquivos Brasileiros de Cardiologia. 2009; 93: e11–3. https://doi.org/10.1590/S0066-782X2009000700016 PMid:19838458

Khera AV, Emdin CA, Drake I, et al. Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. N Engl J Med. 2016; 375(24):2349-58. https://doi.org/10.1056/NEJMoa1605086 PMid:27959714 PMCid:PMC5338864

Canoy D, Beral V, Balkwill A, Wright FL, Kroll ME, Reeves GK, et al. Age at menarche and risks of coronary heart and other vascular diseases in a large UK cohort. Circulation. 2015; 131(3):237–44. https://doi.org/10.1161/CIRCULATIONAHA.114.010070 PMid:25512444

Merz CNB, Johnson BD, Berga S, Braunstein G, Reis SE, Bittner V. Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Fertil Steril. 2006; 85(5):1425–31. https://doi.org/10.1016/j.fertnstert.2006.01.009 PMid:16600235

Matthews KA, Gibson CJ, EI Khoudary SR, Thurston RC. Changes in Cardiovascular Risk Factors by Hysterectomy Status with and without Oophorectomy: Study of Women's Health across the Nation. Journal of the American College of Cardiology. 2013; 62:191–200. https://doi.org/10.1016/j.jacc.2013.04.042 PMid:23684687 PMCid:PMC3777736

Nesello PFT, Foletto G, Comparsi EP, Tairova OS. Change in Profile of Entrants in a Brazilian Large Cardiovascular Rehabilitation Service. Open Access Maced J Med Sci. 2015; 3:384–90. https://doi.org/10.3889/oamjms.2015.083 PMid:27275255 PMCid:PMC4877824

Suaya JA, Shepard DS, Normand S-LT, Ades PA, Prottas J, Stason WB. Use of Cardiac Rehabilitation by Medicare Beneficiaries After Myocardial Infarction or Coronary Bypass Surgery. Circulation. 2007; 116(15):1653-1662. https://doi.org/10.1161/CIRCULATIONAHA.107.701466 PMid:17893274

Snader CE, Marwick TH, Pashkow FJ, Harvey SA, Thomas JD, Lauer MS. Importance of Estimated Functional Capacity as a Predictor of All-Cause Mortality Among Patients Referred for Exercise Thallium Single-Photon Emission Computed Tomography: Report of 3,400 Patients From a Single Center. J Am Coll Cardiol. 1997; 30(3):641-648. https://doi.org/10.1016/S0735-1097(97)00217-9

Published
2018-08-14
How to Cite
1.
Tairova MS, Graciolli LO, Tairova OS, De Marchi T. Analysis of Cardiovascular Disease Risk Factors in Women. Open Access Maced J Med Sci [Internet]. 2018Aug.14 [cited 2020Nov.29];6(8):1370-5. Available from: https://www.id-press.eu/mjms/article/view/oamjms.2018.274
Section
B - Clinical Sciences